METI MEDI

Anti-cancer preparations; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for immunity adjustment; Vaccines; Pharmaceutical agents for regenerating cells; Anti-inflammatory preparations; Pharmaceutical agents affecting digestive organs; Cardiovascular pharmaceutical preparations; Chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Chemico-pharmaceutical preparations, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Pharmaceuticals for medical purposes for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Antibacterial substances for medical purposes; Antibodies for medical purposes for the treatment of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Chemical preparations for medical purpose, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Diagnostic kits for medical diagnostic purposes comprising reagents for use in disease testing, health monitoring and more generally, predictive and preventive medicine in the fields of detecting immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Diagnostic pharmaceutical preparations for medical purposes; Antibiotics; Tumor suppressing agents; Chemotherapeutics